Medacta Group S.A. (MEDGF) Stock Price & Growth Analysis

Quote Panel

Updated October 18, 2025

1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y 1.01 %

Key Metrics

Market Cap
1.67B
Shares Outstanding
19.92M
Share in Float
5.99M
Dividende
0.4094

Earning Date
No Data
Price Target
83.91
Average Volume
9.57895
Beta
1.116

Range
83.91-83.91
Industry
Medical - Devices
Website
https://www.medacta.com
Sector
Healthcare

Quote Panel

Updated October 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

83.91x

P/E Ratio

4.92x

P/S Ratio

7.50x

P/B Ratio

0.6

Debt/Equity

14.7%

Net Margin

$2.5

EPS

How MEDGF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

MEDGF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

MEDGF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$903M

13%

2026-Revenue

$6.01

18%

2026-EPS

$233M

13%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

UBS

downgrade

Previous: Buy

2025-08-08

Now: Neutral

Credit Suisse

upgrade

Previous: Not converted

2022-04-27

Now: Neutral

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

NA
vs NA

Q4.22

-100%

NA
vs 1.23

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

1
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Q3.24

N/A

NA
vs NA

Q4.24

-100%

NA
vs 1

Sales Growth

YoY

Current

Estimates

Q2.23

+21%

255.1M vs 211.3M

Q3.23

NA vs NA

Q4.23

+13%

255.6M vs 225.9M

Q1.24

NA vs NA

Q2.24

+13%

288.6M vs 255.1M

Q3.24

NA vs NA

Q4.24

+18%

301.9M vs 255.6M

Q1.25

NA vs NA

Q2.25

+0%

288.9M vs 288.6M

Q3.25

342.3M vs NA

Return on Equity

QoQ

Q1.23

NA
vs NA

Q2.23

+10%

0.1
vs 0.08

Q3.23

NA
vs NA

Q4.23

+6%

0.06
vs 0.1

Q1.24

NA
vs NA

Q2.24

+11%

0.11
vs 0.06

Q3.24

NA
vs NA

Q4.24

+9%

0.09
vs 0.11

Q1.25

NA
vs NA

Q2.25

+14%

0.14
vs 0.09

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

NA
vs NA

Q4.22

-100%

NA
vs 1.23

Q1.23

N/A

NA
vs NA

Q2.23

N/A

NA
vs NA

Q3.23

N/A

NA
vs NA

Q4.23

N/A

1
vs NA

Q1.24

N/A

NA
vs NA

Q2.24

N/A

NA
vs NA

Q3.24

N/A

NA
vs NA

Q4.24

-100%

NA
vs 1

Sales Growth

YoY

Current

Estimates

Q2.23

+21%

255.1M vs 211.3M

Q3.23

NA vs NA

Q4.23

+13%

255.6M vs 225.9M

Q1.24

NA vs NA

Q2.24

+13%

288.6M vs 255.1M

Q3.24

NA vs NA

Q4.24

+18%

301.9M vs 255.6M

Q1.25

NA vs NA

Q2.25

+0%

288.9M vs 288.6M

Q3.25

342.3M vs NA

Return on Equity

QoQ

Q1.23

NA
vs NA

Q2.23

+10%

0.1
vs 0.08

Q3.23

NA
vs NA

Q4.23

+6%

0.06
vs 0.1

Q1.24

NA
vs NA

Q2.24

+11%

0.11
vs 0.06

Q3.24

NA
vs NA

Q4.24

+9%

0.09
vs 0.11

Q1.25

NA
vs NA

Q2.25

+14%

0.14
vs 0.09

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

83.91USD

83.91x

4.92x

7.50x

0.6

14.7%

$2.5

$903M

$6.01

$233M

Earnings Growth

Latest News

Latest News

Earnings Growth

Latest News

$903M

$6.01

$233M

Company Description

83.91USD

83.91x

4.92x

7.50x

0.6

14.7%

$2.5